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BACKGROUND The presence of coronary artery thrombus can poten-
tially interfere with detection of lipid-core plaques (LCP). Several tech-
nologies, such as OCT, are able to visualize the structure of a thrombus
quite well, but have difﬁculty visualizing structures beneath the
thrombus. Diffuse reﬂectance near infrared spectroscopy (NIRS), which
utilizes photons that undergo multiple scattering events, may be able to
detect LCP behind thrombus. We evaluated the ability of a dual-modality
NIRS-IVUS coronary catheter approved for use in patients, to correctly
identify the LCP behind a coronary thrombus.
METHODS Forty autopsy hearts (n ¼ 103 arterial segments) were scan-
ned with a multimodality TVC NIRS-IVUS catheter to identify LCP and
organized thrombus, which is not a frequent ﬁnding. Artery segments
were scanned through blood, and then rinsed with saline and 10% su-
crose, ﬁxed, embedded in parafﬁn, and cut into 2 mm serial tissue blocks.
Thin sections were stained for H&E, picrosirius red, and Movat’s pen-
tachrome, to detect intraluminal thrombus and LCP.
RESULTS Among the 103 segments, one segment contained an orga-
nized thrombus 8 mm in length over a massive LCP 16 mm in length
(Figure 1A). Despite the overlying thrombus, NIRS correctly identiﬁed
the almost circumferential lipid core plaque (Figure 1B). The cross-
sectional NIRS-IVUS results (Figure 1C) show the NIRS detection of
LCP (yellow in halo around IVUS image) and the attenuated plaque
by IVUS.CONCLUSIONS NIRS imaging was able to detect lipid core under a
large, organized thrombus, with no evidence of outliers correspond-
ing to the location of the LCP on the report of NIRS results. This
ﬁnding supports the conduct of additional studies to fully charac-
terize the ability of NIRS to detect LCP in the presence of organized
thrombus.
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BACKGROUND Intense perioperative immunotherapy at time of car-
diac transplantation with antithymocyte globulin (ATG) has been
associated with decreased incidence of angiographic cardiac allograft
vasculopathy (CAV) but its association with coronary plaque pro-
gression on intravascular ultrasound (IVUS) has not been established.
METHODS Between March 2010 and December 2012, patients (pts)
with baseline and 1-yr IVUS were included in the analysis. Plaque
characteristics of matched left main and left anterior descending
segments on baseline and 1-yr IVUS were measured in a blinded
fashion with quantiﬁcation software. Linear regression analyses were
performed on the effect of the number of doses of ATG given for the
IVUS variables of percent atheroma volume, max percent stenosis,
maximal intimal thickness, and maximal intimal area.
RESULTS One-hundred and three pts were included in the analysis.
Mean age at transplant was 55.8  12.6 yrs and 33.0% of pts were fe-
male. 46/103 (44.7%) pts received an average of 3.9  1.2 doses of ATG
at time of transplant. Baseline and 1-yr IVUS were performed at 44.5 
12.1 days and 379.1  27.0 days after transplant, respectively, and
mean IVUS segment length was 37.2  4.2 mm. Pre-transplant peak
panel reactive antibodies was signiﬁcantly higher in pts who were
induced: 40.0  38.9% vs. 9.2  21.7% (p<0.001). The number of ATG
doses given was associated with decreased plaque progression across
all four IVUS metrics by linear regression. Progression of percent
atheroma volume between baseline and 1-yr IVUS was attenuated by
0.67% for each dose of ATG given (p¼0.038). Progression of max
percent stenosis was attenuated by 1.53% for each dose of ATG given
(p¼0.003). Progression of maximal intimal thickness progression was
attenuated by 0.03 mm for each dose of ATG given (p¼0.028). Pro-
gression of maximal intimal area was attenuated by 0.29 mm2 for each
dose of ATG given (p¼0.004). The dose-dependent attenuation of
plaque progression is illustrated in Figure 1.
CONCLUSIONS Coronary plaque progression is attenuated with the
use of ATG induction therapy as assessed by IVUS in a dose-depen-
dent manner across four IVUS metrics. Further investigation is war-
ranted to explore this relationship.
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